COMPASS PATHWAYS PLC Earnings Per Share (Basic)
COMPASS PATHWAYS PLC (CMPS) reported Earnings Per Share (Basic) of -$1.88 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-05
- COMPASS PATHWAYS PLC earnings per share, basic for the quarter ending 2026-06-30 was -$1.88.
- COMPASS PATHWAYS PLC earnings per share, basic for the quarter ending 2026-03-31 was $0.71.
- COMPASS PATHWAYS PLC earnings per share, basic for the quarter ending 2025-09-30 was -$1.44.
- COMPASS PATHWAYS PLC earnings per share, basic for the quarter ending 2025-06-30 was -$0.41.
- COMPASS PATHWAYS PLC earnings per share, basic for fiscal 2025 was -$3.08.
- COMPASS PATHWAYS PLC earnings per share, basic for fiscal 2024 was -$2.30.
- COMPASS PATHWAYS PLC earnings per share, basic for fiscal 2023 was -$2.32.
- COMPASS PATHWAYS PLC earnings per share, basic for fiscal 2022 was -$2.16.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 3 month as first filed | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 6 month as first filed | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | -$1.88 10-Q · filed 2026-08-05 | -$1.33 10-Q · filed 2026-08-05 | ||||
| 2026-03-31 | $0.71 10-Q · filed 2026-05-13 | |||||
| 2025-12-31 | -$3.08 10-K · filed 2026-03-24 | |||||
| 2025-09-30 | -$1.44 10-Q · filed 2025-11-04 | -$2.09 10-Q · filed 2025-11-04 | ||||
| 2025-06-30 | -$0.41 10-Q · filed 2026-08-05 | -$0.62 10-Q · filed 2026-08-05 | ||||
| 2025-03-31 | -$0.20 10-Q · filed 2026-05-13 | |||||
| 2024-12-31 | -$2.30 10-K · filed 2026-03-24 | |||||
| 2024-09-30 | -$0.56 10-Q · filed 2025-11-04 | -$1.67 10-Q · filed 2025-11-04 | ||||
| 2024-06-30 | -$0.56 10-Q · filed 2025-07-31 | -$560.00 10-Q · filed 2024-08-01 | -$1.11 10-Q · filed 2025-07-31 | -$1110.00 10-Q · filed 2024-08-01 | ||
| 2024-03-31 | -$0.55 10-Q · filed 2025-05-08 | -$1.07 derived: net income ÷ weighted average shares · filed 2025-05-08 | -$1.72 derived: net income ÷ weighted average shares · filed 2025-05-08 | -$2.34 derived: net income ÷ weighted average shares · filed 2025-05-08 | ||
| 2023-12-31 | -$0.52 derived: net income ÷ weighted average shares · filed 2025-02-27 | -$1.18 derived: net income ÷ weighted average shares · filed 2025-02-27 | -$1.80 derived: net income ÷ weighted average shares · filed 2025-02-27 | -$2.32 10-K · filed 2025-02-27 | ||
| 2023-09-30 | -$0.67 10-Q · filed 2024-10-31 | -$1.30 derived: net income ÷ weighted average shares · filed 2024-10-31 | -$1.81 10-Q · filed 2024-10-31 | -$2.59 derived: net income ÷ weighted average shares · filed 2024-10-31 | ||
| 2023-06-30 | -$620.00 10-Q · filed 2024-08-01 | -$0.62 10-Q · filed 2023-08-03 | -$1190.00 10-Q · filed 2024-08-01 | -$1.19 10-Q · filed 2023-08-03 | -$1.91 derived: net income ÷ weighted average shares · filed 2024-08-01 | -$2.35 derived: net income ÷ weighted average shares · filed 2024-08-01 |
| 2023-03-31 | -$0.57 10-Q · filed 2024-05-08 | -$1.29 derived: net income ÷ weighted average shares · filed 2024-05-08 | -$1.72 derived: net income ÷ weighted average shares · filed 2024-05-08 | -$2.22 derived: net income ÷ weighted average shares · filed 2024-05-08 | ||
| 2022-12-31 | -$0.73 derived: net income ÷ weighted average shares · filed 2024-02-29 | -$1.16 derived: net income ÷ weighted average shares · filed 2024-02-29 | -$1.65 derived: net income ÷ weighted average shares · filed 2024-02-29 | -$2.16 10-K · filed 2024-02-29 | ||
| 2022-09-30 | -$0.43 10-Q · filed 2023-11-02 | -$0.93 derived: net income ÷ weighted average shares · filed 2023-11-02 | -$1.43 10-Q · filed 2023-11-02 | -$2.04 derived: net income ÷ weighted average shares · filed 2024-02-29 | ||
| 2022-06-30 | -$0.50 10-Q · filed 2023-08-03 | -$1.00 10-Q · filed 2023-08-03 | -$1.61 derived: net income ÷ weighted average shares · filed 2024-02-29 | -$1.99 derived: net income ÷ weighted average shares · filed 2024-02-29 | ||
| 2022-03-31 | -$0.50 10-Q · filed 2023-05-11 | -$1.12 derived: net income ÷ weighted average shares · filed 2024-02-29 | -$1.50 derived: net income ÷ weighted average shares · filed 2024-02-29 | -$1.94 derived: net income ÷ weighted average shares · filed 2024-02-29 | ||
| 2021-12-31 | -$0.61 derived: net income ÷ weighted average shares · filed 2024-02-29 | -$0.99 derived: net income ÷ weighted average shares · filed 2024-02-29 | -$1.44 derived: net income ÷ weighted average shares · filed 2024-02-29 | -$1.79 10-K · filed 2024-02-29 | ||
| 2021-09-30 | -$0.38 10-Q · filed 2022-11-03 | -$0.82 derived: net income ÷ weighted average shares · filed 2022-11-03 | -$1.17 10-Q · filed 2022-11-03 | -$1.68 derived: net income ÷ weighted average shares · filed 2023-02-28 | ||
| 2021-06-30 | -$0.44 10-Q · filed 2022-08-04 | -$0.79 10-Q · filed 2022-08-04 | -$1.31 derived: net income ÷ weighted average shares · filed 2023-02-28 | -$1.68 derived: net income ÷ weighted average shares · filed 2023-02-28 | ||
| 2021-03-31 | -$0.35 10-Q · filed 2022-05-10 | -$0.87 derived: net income ÷ weighted average shares · filed 2023-02-28 | -$1.24 derived: net income ÷ weighted average shares · filed 2023-02-28 | -$1.68 derived: net income ÷ weighted average shares · filed 2023-02-28 | ||
| 2020-12-31 | -$0.52 derived: net income ÷ weighted average shares · filed 2023-02-28 | -$0.89 derived: net income ÷ weighted average shares · filed 2023-02-28 | -$1.33 derived: net income ÷ weighted average shares · filed 2023-02-28 | -$3.55 10-K · filed 2023-02-28 | ||
| 2020-09-30 | -$0.38 10-Q · filed 2022-11-03 | -$1.30 6-K · filed 2021-11-09 | -$0.82 derived: net income ÷ weighted average shares · filed 2022-11-03 | -$3.90 6-K · filed 2021-11-09 | ||
| 2020-06-30 | -$0.44 10-Q · filed 2022-08-04 | -$1.65 6-K · filed 2021-08-11 | -$2.61 6-K · filed 2021-08-11 | |||
| 2019-12-31 | -$2.62 10-K · filed 2022-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ANI PHARMACEUTICALS INC (ANIP) | United States | $1.810B | 18.77 |
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |
| Xencor Inc (XNCR) | United States | $1.776B | -7.33 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |